Search Results - "Larrayoz M"

Copy Number Alterations Suggest a Functional Switch from Innate Immunity to DNA Repair and Drive Clinical Heterogeneity in Plasma Cell Dyscrasias.

Authors: Barreto, Igor Valentim Ferreira, Wallax Augusto Silva Morais, Guilherme Passos de et al.

Source: International Journal of Translational Medicine. Jun2026, Vol. 6 Issue 2, p21. 21p.

Genetically driven immune microenvironment states associate with therapeutic responses in MYD88 mutant lymphomas.

Authors: Celay J Recalde M Revuelta MV et al.

Source: Molecular cancer [Mol Cancer] 2026 Apr 20. Date of Electronic Publication: 2026 Apr 20.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response.

Authors: Cenzano I Cócera M Larrayoz M et al.

Source: Nature communications [Nat Commun] 2026 Jun 23. Date of Electronic Publication: 2026 Jun 23.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Longitudinal Whole-Exome Sequencing Identifies Clonal Hematopoiesis and Genomic Heterogeneity as a Predictor of Treatment Outcome in Patients with Newly Diagnosed, Elderly Chronic Lymphocytic Leukemia.

Authors: Jang, Ho Cheol Song, Ga-Young Jeong, Hyeonjin et al.

Source: International Journal of Molecular Sciences. Mar2026, Vol. 27 Issue 6, p2610. 14p.

Elevated Allele Frequency of a Common Germline LAG3 Variant Associated with Anemia, Thrombocytopenia and Peripheral Blast Percentage in Acute Myeloid Leukemia.

Authors: Seipel, Katja Shaforostova, Inna Tarozzi, Elisa et al.

Source: Cancers. May2026, Vol. 18 Issue 10, p1671. 12p.

Characterization of the bone marrow architecture of multiple myeloma using spatial transcriptomics.

Authors: Muiños-Lopez, Emma Lopez-Perez, Ana Rosa Sudupe, Laura et al.

Source: Communications Biology. 11/20/2025, Vol. 8 Issue 1, p1-15. 15p.

Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myeloma.

Authors: Bjorklund CC Larrayoz M Kang J et al.

Source: Blood neoplasia [Blood Neoplasia] 2025 Nov 07; Vol. 3 (1), pp. 100179. Date of Electronic Publication: 2025 Nov 07 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE

Targeting CDK11 in Rhabdoid Tumor of the Kidney.

Authors: Murakami, Yuki Lam, Kamhung Fukui, Shinsuke et al.

Source: Cancers. Jan2026, Vol. 18 Issue 2, p261. 12p.

Functional Intraclonal Heterogeneity in Chronic Lymphocytic Leukemia: Proliferation vs. Quiescence.

Authors: Friedman, Daniel Patten, Piers E. M. Hoogeboom, Robbert

Source: Lymphatics. Dec2025, Vol. 3 Issue 4, p47. 8p.

Complex TP53 Alterations with del(17p) and del(13q) in Chronic Lymphocytic Leukemia: Clinical Implications from a Case-Based Review.

Authors: Balla, Beata Crauciuc, Andrei Lazar, Erzsebet et al.

Source: International Journal of Molecular Sciences. Jul2026, Vol. 27 Issue 13, p5843. 18p.

Metabolic modulation of immune cell function: mechanisms and therapeutic implications in cancer immunotherapy.

Authors: Fenouille, Nina Lobry, Camille Benajiba, Lina et al.

Source: Oncogenesis. 5/7/2026, Vol. 15 Issue 1, p1-18. 18p.

Single-cell technologies in deciphering drug resistance of multiple myeloma: mechanistic insights and clinical translation prospects.

Authors: Wu, Jun Dong, Haibo Xu, Xuejing et al.

Source: Leukemia & Lymphoma. May2026, Vol. 67 Issue 6, p1231-1246. 16p.

Heme oxygenase 1 confers gilteritinib resistance in FLT3-ITD acute myeloid leukemia in a STAT6-dependent manner.

Authors: Zhang, Tianzhuo Wei, Danna Zhan, Yun et al.

Source: Cancer Cell International. 4/4/2025, Vol. 25 Issue 1, p1-12. 12p.

PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD.

Authors: Lanza, Marika Basilotta, Rossella Caccamo, Antonella et al.

Source: Cells (2073-4409). Sep2025, Vol. 14 Issue 18, p1474. 19p.

Prognostic significance of in patients with chronic lymphocytic leukemia: A meta-analysis.

Authors: Huang L Shi X Tang N et al.

Source: Annals of hematology [Ann Hematol] 2025 Aug; Vol. 104 (8), pp. 3943-3962. Date of Electronic Publication: 2025 Jul 30.

Publication Type: Journal Article; Meta-Analysis; Review

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

ON MODELLING OF THREE DIMENSIONAL FLOW IN EXTRACTION OF BIOLOGICALLY ACTIVE SUBSTANCES FROM PLANTS.

Authors: Strautins, Uldis Marinaki, Maksims

Source: Engineering for Rural Development - International Scientific Conference. 2023, p204-209. 6p.

Metabolization of microbial postbiotic pentanoate drives anti-cancer CAR T cells.

Authors: Staudt S Nikolka F Perl M et al.

Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Feb 04. Date of Electronic Publication: 2025 Feb 04.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

SSTNIV, a syndecan-1-targeting peptide chimera, reverses immune suppression and inhibits myeloma progression.

Authors: Jung O Beauvais DM Ibaan GL et al.

Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 May 12; Vol. 11 (1). Date of Electronic Publication: 2026 May 12.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

Tregs at Diagnosis as a Potential Biomarker for Predicting High‐Risk Functionality in Newly Diagnosed Multiple Myeloma.

Authors: Zhou, Qiaolin Xu, Fang Wen, Jingjing et al.

Source: Cancer Medicine. Jun2025, Vol. 14 Issue 11, p1-9. 9p.

T-lymphocytes suppression by CD14⁺ monocytes with high expression of ULK2 in patients with multiple myeloma.

Authors: Peng, Fengping Liu, Zhaoyun Jiang, Fengjuan et al.

Source: Journal of Translational Medicine. 5/7/2025, Vol. 23 Issue 1, p1-14. 14p.